Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Current Liabilities (2016 - 2025)

Haemonetics has reported Total Current Liabilities over the past 16 years, most recently at $539.9 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $539.9 million for Q4 2025, up 113.19% from a year ago — trailing twelve months through Dec 2025 was $539.9 million (up 113.19% YoY), and the annual figure for FY2025 was $578.1 million, up 92.46%.
  • Total Current Liabilities for Q4 2025 was $539.9 million at Haemonetics, down from $548.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for HAE hit a ceiling of $578.1 million in Q1 2025 and a floor of $180.5 million in Q3 2022.
  • Median Total Current Liabilities over the past 5 years was $263.2 million (2022), compared with a mean of $326.9 million.
  • Biggest five-year swings in Total Current Liabilities: tumbled 44.01% in 2021 and later soared 113.19% in 2025.
  • Haemonetics' Total Current Liabilities stood at $288.5 million in 2021, then decreased by 21.35% to $226.9 million in 2022, then grew by 15.37% to $261.8 million in 2023, then fell by 3.26% to $253.2 million in 2024, then soared by 113.19% to $539.9 million in 2025.
  • The last three reported values for Total Current Liabilities were $539.9 million (Q4 2025), $548.3 million (Q3 2025), and $531.4 million (Q2 2025) per Business Quant data.